biomarker
-
apceth, Indivumed to develop biomarker platform for targeted cellular therapies
apceth and Indivumed have entered into a partnership for the development of a predominantly tissue-based biomarker strategy for the treatment of solid cancers with cellular and / or gene therapeutics.
biomarker | 27 March 2012
-
Biomarkers Consortium of the FNIH selects ICON to support study evaluating variability in insulin secretory parameters
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced it has received a contract award from the Foundation for the National Institutes of Health (FNIH) to provide clinical support for the Biomarkers Consortium study entitled Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects.
biomarker | 31 October 2011
-
Roche and Evotec to jointly develop biomarkers in oncology
An alliance for personalized healthcare in cancer research and development.
biomarker | 24 June 2011
-
Multiplex immunoassay platform validates prognostic and predictive protein biomarkers
Data was presented at the recent American Society of Clinical Oncology's 2011 Genitourinary Cancers Symposium showing multiple protein biomarkers predictive of clinical benefit and prognostic of disease outcome in patients with advanced or metastatic…
biomarker | 13 June 2011
-
KineMed to demonstrate biomarker probes at 2011 World Pharmaceutical Congress
KineMed Inc announced that Dr Mahalakshmi Shankaran, PhD, Director of Neurobiology, will present at the 2011 World Pharmaceutical Congress on June 7th at Philadelphia, PA, USA. Dr Shankaran’s presentation, entitled “Novel Tissue and CSF Bioma…
biomarker | 23 May 2011
-
Protein biomarker analysis
The SignaturePLUS system is designed to meet the cost and performance needs of researchers for accurate, reproducible, and reliable multiplex protein biomarker analysis across pre-clinical, clinical and diagnostics applications in all therapeutic ar…
biomarker | 01 May 2011
-
Imaging biomarkers
Large pharma has been seeking new biomarkers for years – all part of their drug discovery process, but often only as an afterthought in the development process. That’s changed over recent years, but by-and-large the bulk of biomarker work rem…
biomarker | 16 November 2010
-
Collaboration in protein biomarker research
The collaboration unites the proteomics reagent team at the Thermo Fisher Scientific Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center with Proteome Sciences (PS) to further develop quantitative proteomic workflows that are based on …
biomarker | 19 October 2010
-
Quantitative and focused proteomics for biomarker discovery
Efficient applications of mass spectrometric technology can lead to sensitive and high-throughput identification of clinically useful biomarkers.
biomarker | 01 October 2010
-
Funding enables use of Solid 4 for cancer biomarker research
Life Technologies and University of California at San Diego (UCSD) Moores Cancer Center announces a partnership to use Solid 4 genomic analysis technology in a research program to study chronic lymphocytic leukemia (CLL), a cancer of the white blood…
biomarker | 24 August 2010
